Results 161 to 170 of about 75,632 (172)

A multi-antigen vaccinia vaccine broadly protected mice against SARS-CoV-2 and influenza A virus while also targeting SARS-CoV-1 and MERS-CoV. [PDF]

Front Immunol
Gao N, Yang T, Dong L, Tang W, Cao K, Ding L, Zhu C, Bai S, Xia A, Zhu Y, Zhao C, Peng H, Xu J, Zhang X.   +13 more
europepmc   +1 more source

Sulfated Glycans Inhibit the Interaction of MERS-CoV Receptor Binding Domain with Heparin. [PDF]

Viruses
Yang J, Song Y, Jin W, Xia K, Burnett GC, Qiao W, Bates JT, Pomin VH, Wang C, Qiao M, Linhardt RJ, Dordick JS, Zhang F.   +12 more
europepmc   +1 more source

A Structural Comparison of Oral SARS-CoV-2 Drug Candidate Ibuzatrelvir Complexed with the Main Protease (M^pro) of SARS-CoV-2 and MERS-CoV. [PDF]

JACS Au
Chen P, Van Oers TJ, Arutyunova E, Fischer C, Wang C, Lamer T, van Belkum MJ, Young HS, Vederas JC, Lemieux MJ.   +9 more
europepmc   +1 more source

Inactivated Split MERS-CoV Antigen Prevents Lethal Middle East Respiratory Syndrome Coronavirus Infections in Mice. [PDF]

Vaccines (Basel)
Seo H, Jang Y, Kwak D.
europepmc   +1 more source

Retracted: Computer-Aided Prediction and Identification of Phytochemicals as Potential Drug Candidates against MERS-CoV. [PDF]

Biomed Res Int
International BR.
europepmc   +1 more source

The effectiveness of intervention measures on MERS-CoV transmission by using the contact networks reconstructed from link prediction data. [PDF]

Front Public Health
Kim E, Kim Y, Jin H, Lee Y, Lee H, Lee S.   +5 more
europepmc   +1 more source

Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir. [PDF]

Npj Viruses
Krismer L, Schöppe H, Rauch S, Bante D, Sprenger B, Naschberger A, Costacurta F, Fürst A, Sauerwein A, Rupp B, Kaserer T, von Laer D, Heilmann E.   +12 more
europepmc   +1 more source

An in silico approach to develop potential therapies against Middle East Respiratory Syndrome Coronavirus (MERS-CoV). [PDF]

Heliyon
Biswas S, Mita MA, Afrose S, Hasan MR, Shimu MSS, Zaman S, Saleh MA.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

MERS-CoV Infection

2021
Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging pathogen associated with severe respiratory symptoms and renal failure in infected persons and mild-to-subclinical infection in dromedary camels. MERS-CoV causes nowell-defined disease in camels and its impact of MERS-CoV on animal health is exceptionally low.
openaire   +2 more sources

Managing MERS-CoV in the healthcare setting

Hospital Practice, 2015
Middle East respiratory Syndrome Coronavirus (MERS-CoV) has caused at least 1118 reported cases in 24 countries with at least 423 deaths worldwide. All cases are epidemiologically linked to the Arabian Penninsula with most cases reported from the Kingdom of Saudi Arabia.
Ziad A. Memish, Jaffar A. Al-Tawfiq
openaire   +2 more sources